1. Market Research
  2. > Healthcare Market Trends

2014 Life Sciences Outlook in Turkey : Rapid Economic Development and Healthcare Reforms Set the Stage for the Future

  • November 2014
  • 108 pages
  • Frost & Sullivan
Report ID: 2470297


Table of Contents

Executive Summary

•The purpose of this study is to analyze the Turkish life sciences market, which includes the pharmaceuticals segment and the clinical diagnostics segment. In 2013, the life sciences market revenue in Turkey was valued at $x billion, growing at x% from 2012 to 2013.
•Rapid economic growth and the healthcare transformation program have generated a significant increase in healthcare expenditure between 2003 and 2011 in Turkey. The national healthcare expenditure of Turkey grew from $xbillion in 2006 to $x billion in 2013, registering a strong year-over-year (YOY) growth of x% during this period. The life sciences market in Turkey will witness more growth than mature markets such as those in the United States, Japan, and Europe.
•Rapid socio-economic development in Turkey has resulted in an increasing trend in non-communicable diseases such as coronary diseases, cancer, diabetes, hypertension, obesity, and chronic obstructive pulmonary diseases. In 2012, coronary diseases, cancer, and respiratory diseases accounted for more than x% of the hospital deaths in Turkey.
•In 2003, a series of changes and innovations was implemented to qualify the health services provision in accordance with modern standards and to render it more efficient, effective, and accessible through the Health Transformation Program (HTP) by the fifty-ninth government.
•The pharmaceuticals segment is the 14th largest worldwide and the 6th largest in Europe. This segment was valued at $x billion in 2013 and is expected to grow at a compound annual growth rate (CAGR) of x%, reaching $xbillion in 2018. Biotechnology-based drugs, diabetes, respiratory, and oncology drugs will exert the highest growth rates in the segment.
•The clinical diagnostics segment was valued at $x billion in 2013 and is expected to grow to at a CAGR of x%, reaching $xbillion by 2018.
•Following the centralization of the x former social security institutes (SSI) into a single SSI called Sosyal Guvenlik Kurumu (SGK), the social security system in Turkey underwent a significant transformation, resulting in a faster and more efficient health coverage system. Currently, % of Turkey’s total population is covered by the SGK.
•Turkey’s pharmaceuticals segment is dominated by international companies that constituted a combined share of x% in 2012. Local manufacturers, including Abdi Ibrahim (x% market share) and Bilim Ilac (x% market share), were among the top x pharmaceutical companies in Turkey.
•Because of huge capital investments and long research periods, Turkey does not conduct new molecule research. Research is mainly conducted on improving products and new formulations.

Study Scope

•This study provides an overview of the life sciences market in Turkey and its various therapeutic segments and product classes.
•For this research, life sciences market covers xmain segments: pharmaceuticals and clinical diagnostics.
•For the purpose of this research, the pharmaceuticals segment includes both drugs (small molecules) and biotechnology-based products (large molecules).
•In addition to market size and revenue forecast, detailed segment analysis has been provided for the pharmaceuticals segment with respect to investment trends, government reforms, regulatory policies, market shares, and key stakeholders.
•For the clinical diagnostics segment, top-line numbers and revenue forecasts have been provided.
•Revenues from medical devices and the private health care services segment are not included in this study.
•Other advanced medical technologies such as imaging, vital signs monitoring, and other tools used to diagnose and monitor patient conditions are not covered in this study.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Gas Chromatography Market by Instrument, Accessories and Consumables,End user - Global Forecast to 2022

  • $ 5650
  • Industry report
  • May 2017
  • by MarketsandMarkets

The global gas chromatography market is expected to reach USD 3.67 billion by 2022 from USD 2.64 billion in 2016, at a CAGR of 6.2%. In this report, the gas chromatography market is segmented on the basis ...

Chromatography Instruments Market by Type, Consumables and Accessories, Applications, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Chromatography instruments market is projected to grow at a CAGR of 6.9%” The global chromatography instruments market is estimated to grow at a CAGR of 6.9% from 2017 to 2022, to reach USD 10.99 ...

Biochips (Microarrays/Microfluidics) Global Market – Forecast To 2023

  • $ 4950
  • Industry report
  • June 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.